2025年“全国药品安全宣传周”活动启动

Group 1 - The core theme of the "National Drug Safety Publicity Week" launched by the National Medical Products Administration (NMPA) is "Drug Safety, Regulation for the People" [1] - During the 14th Five-Year Plan period, the demand for medication among the public has been increasingly met, leading to a more stable and consolidated drug safety situation, along with positive innovation in the pharmaceutical industry [1] - Over the past five years, China has approved 210 innovative drugs and 269 innovative medical devices, both showing a trend of accelerated growth [1] Group 2 - China's biopharmaceutical market has become the second largest globally, with approximately 30% of the world's innovative drugs under research [1] - The NMPA has continuously improved the regulatory enforcement system for drugs, conducting special rectification actions and enhancing drug safety measures [1] - The national drug sampling inspection pass rate has remained stable at over 99.4%, effectively ensuring the safety of medications for the public [1]